HEADER TRANSFERASE 25-FEB-17 5N9N TITLE CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN TITLE 2 COMPLEX WITH THE ATP-COMPETITIVE, TIGHT-BINDING DIBENZOFURAN TITLE 3 INHIBITOR TF85 (4A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-335; COMPND 5 SYNONYM: CK II ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, CK2, CASEIN KINASE 2, PROTEIN PHOSPHORYLATION, ATP- KEYWDS 2 COMPETITIVE INHITITORS, DIBENZOFURAN DERIVATIVES, TRANSFERASE, KEYWDS 3 TIGHT-BINDING INHIBITORS EXPDTA X-RAY DIFFRACTION AUTHOR A.SCHNITZLER,A.GRATZ,A.BOLLACKE,M.WEYRICH,U.KUCKLAENDER,B.WUENSCH, AUTHOR 2 C.GOETZ,K.NIEFIND,J.JOSE REVDAT 6 17-JAN-24 5N9N 1 REMARK REVDAT 5 22-MAY-19 5N9N 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 HETSYN FORMUL SITE ATOM REVDAT 4 25-APR-18 5N9N 1 JRNL REVDAT 3 18-APR-18 5N9N 1 JRNL REVDAT 2 07-MAR-18 5N9N 1 JRNL REVDAT 1 28-FEB-18 5N9N 0 JRNL AUTH A.SCHNITZLER,A.GRATZ,A.BOLLACKE,M.WEYRICH,U.KUCKLANDER, JRNL AUTH 2 B.WUNSCH,C.GOTZ,K.NIEFIND,J.JOSE JRNL TITL A PI-HALOGEN BOND OF DIBENZOFURANONES WITH THE GATEKEEPER JRNL TITL 2 PHE113 IN HUMAN PROTEIN KINASE CK2 LEADS TO POTENT TIGHT JRNL TITL 3 BINDING INHIBITORS. JRNL REF PHARMACEUTICALS V. 11 2018 JRNL REFN ESSN 1424-8247 JRNL PMID 29462988 JRNL DOI 10.3390/PH11010023 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH I.ERMAKOVA,B.BOLDYREFF,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN REMARK 1 TITL 2 PROTEIN KINASE CK2 CATALYTIC SUBUNIT. REMARK 1 REF J. MOL. BIOL. V. 330 925 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12860116 REMARK 1 DOI 10.1016/S0022-2836(03)00638-7 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.W.YDE,I.ERMAKOVA,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL INCLINING THE PURINE BASE BINDING PLANE IN PROTEIN KINASE REMARK 1 TITL 2 CK2 BY EXCHANGING THE FLANKING SIDE-CHAINS GENERATES A REMARK 1 TITL 3 PREFERENCE FOR ATP AS A COSUBSTRATE. REMARK 1 REF J. MOL. BIOL. V. 347 399 2005 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 15740749 REMARK 1 DOI 10.1016/J.JMB.2005.01.003 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.NIEFIND,N.BISCHOFF,A.G.GOLUB,V.G.BDZHOLA,A.O.BALANDA, REMARK 1 AUTH 2 A.O.PRYKHOD'KO,S.M.YARMOLUK REMARK 1 TITL STRUCTURAL HYPERVARIABILITY OF THE TWO HUMAN PROTEIN KINASE REMARK 1 TITL 2 CK2 CATALYTIC SUBUNIT PARALOGS REVEALED BY COMPLEX REMARK 1 TITL 3 STRUCTURES WITH A FLAVONOL- AND A REMARK 1 TITL 4 THIENO[2,3-D]PYRIMIDINE-BASED INHIBITOR. REMARK 1 REF PHARMACEUTICALS (BASEL) V. 10 2017 REMARK 1 REFN ESSN 1424-8247 REMARK 1 PMID 28085026 REMARK 1 DOI 10.3390/PH10010009 REMARK 1 REFERENCE 4 REMARK 1 AUTH C.GOETZ,A.GRATZ,U.KUCKLAENDER,J.JOSE REMARK 1 TITL TF--A NOVEL CELL-PERMEABLE AND SELECTIVE INHIBITOR OF HUMAN REMARK 1 TITL 2 PROTEIN KINASE CK2 INDUCES APOPTOSIS IN THE PROSTATE CANCER REMARK 1 TITL 3 CELL LINE LNCAP. REMARK 1 REF BIOCHIM. BIOPHYS. ACTA V.1820 970 2012 REMARK 1 REFN ISSN 0006-3002 REMARK 1 PMID 22387500 REMARK 1 DOI 10.1016/J.BBAGEN.2012.02.009 REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.17 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 25774 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1317 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.1705 - 3.8268 0.96 2816 139 0.1503 0.1567 REMARK 3 2 3.8268 - 3.0381 0.97 2752 159 0.1480 0.2015 REMARK 3 3 3.0381 - 2.6542 0.97 2752 159 0.1733 0.2253 REMARK 3 4 2.6542 - 2.4116 0.97 2739 164 0.1784 0.2119 REMARK 3 5 2.4116 - 2.2388 0.97 2734 144 0.1717 0.2050 REMARK 3 6 2.2388 - 2.1068 0.97 2740 131 0.1760 0.2099 REMARK 3 7 2.1068 - 2.0013 0.96 2722 142 0.1899 0.2542 REMARK 3 8 2.0013 - 1.9142 0.96 2678 132 0.2265 0.2355 REMARK 3 9 1.9142 - 1.8405 0.90 2524 147 0.2703 0.2907 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2952 REMARK 3 ANGLE : 0.568 3986 REMARK 3 CHIRALITY : 0.044 404 REMARK 3 PLANARITY : 0.005 512 REMARK 3 DIHEDRAL : 13.196 1746 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 2 THROUGH 87 ) REMARK 3 ORIGIN FOR THE GROUP (A): -18.4634 3.2329 45.9685 REMARK 3 T TENSOR REMARK 3 T11: 0.2775 T22: 0.4354 REMARK 3 T33: 0.3595 T12: -0.0985 REMARK 3 T13: -0.0017 T23: 0.0783 REMARK 3 L TENSOR REMARK 3 L11: 3.0921 L22: 2.2939 REMARK 3 L33: 0.9323 L12: -1.6733 REMARK 3 L13: 0.2757 L23: 0.0498 REMARK 3 S TENSOR REMARK 3 S11: 0.0968 S12: -0.2322 S13: -0.4706 REMARK 3 S21: 0.0109 S22: -0.0532 S23: 0.4108 REMARK 3 S31: 0.1987 S32: -0.3858 S33: -0.0274 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 88 THROUGH 149 ) REMARK 3 ORIGIN FOR THE GROUP (A): -10.7061 13.7652 50.3736 REMARK 3 T TENSOR REMARK 3 T11: 0.2490 T22: 0.3267 REMARK 3 T33: 0.2368 T12: 0.0205 REMARK 3 T13: 0.0257 T23: 0.0447 REMARK 3 L TENSOR REMARK 3 L11: 5.2484 L22: 0.9578 REMARK 3 L33: 1.3515 L12: 0.7050 REMARK 3 L13: 1.3312 L23: 0.6791 REMARK 3 S TENSOR REMARK 3 S11: -0.1267 S12: -0.3786 S13: 0.2396 REMARK 3 S21: -0.0512 S22: 0.0894 S23: 0.2635 REMARK 3 S31: -0.0964 S32: -0.2338 S33: 0.0110 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 150 THROUGH 280 ) REMARK 3 ORIGIN FOR THE GROUP (A): 1.9081 7.2364 37.6150 REMARK 3 T TENSOR REMARK 3 T11: 0.2033 T22: 0.1579 REMARK 3 T33: 0.1719 T12: -0.0100 REMARK 3 T13: -0.0261 T23: 0.0362 REMARK 3 L TENSOR REMARK 3 L11: 2.8672 L22: 1.3928 REMARK 3 L33: 2.2934 L12: -0.1543 REMARK 3 L13: -0.4845 L23: 0.2742 REMARK 3 S TENSOR REMARK 3 S11: 0.0234 S12: 0.0510 S13: -0.0101 REMARK 3 S21: -0.1830 S22: 0.0219 S23: 0.0768 REMARK 3 S31: -0.0399 S32: -0.0076 S33: -0.0524 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 281 THROUGH 329 ) REMARK 3 ORIGIN FOR THE GROUP (A): 10.6639 13.4452 48.7537 REMARK 3 T TENSOR REMARK 3 T11: 0.1832 T22: 0.2409 REMARK 3 T33: 0.2225 T12: -0.0121 REMARK 3 T13: -0.0009 T23: -0.0017 REMARK 3 L TENSOR REMARK 3 L11: 1.9106 L22: 3.6641 REMARK 3 L33: 2.7467 L12: -0.3337 REMARK 3 L13: 0.1602 L23: 1.3703 REMARK 3 S TENSOR REMARK 3 S11: -0.0521 S12: -0.1239 S13: 0.1012 REMARK 3 S21: -0.0100 S22: 0.1410 S23: -0.1168 REMARK 3 S31: -0.0719 S32: 0.2525 S33: -0.0954 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 330 THROUGH 330 ) REMARK 3 ORIGIN FOR THE GROUP (A): -2.9863 14.8291 65.7176 REMARK 3 T TENSOR REMARK 3 T11: 0.8733 T22: 1.7716 REMARK 3 T33: 1.8161 T12: 0.3647 REMARK 3 T13: -0.1879 T23: -0.1627 REMARK 3 L TENSOR REMARK 3 L11: 7.9969 L22: 4.3402 REMARK 3 L33: 9.5503 L12: 2.5798 REMARK 3 L13: -3.1576 L23: -1.1715 REMARK 3 S TENSOR REMARK 3 S11: 0.8831 S12: 9.7801 S13: -0.5114 REMARK 3 S21: -0.4413 S22: -2.2184 S23: 2.7451 REMARK 3 S31: -1.9659 S32: 6.2135 S33: 1.3435 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5N9N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1200003735. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25795 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.840 REMARK 200 RESOLUTION RANGE LOW (A) : 45.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.75000 REMARK 200 R SYM FOR SHELL (I) : 0.75000 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2PVR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PRIOR TO THE CRYSTALLIZATION THE REMARK 280 INHIBITOR TF85 WAS SOLUBILIZED IN 100 % DMSO IN A CONCENTRATION REMARK 280 OF 10 MM. THIS TF85 STOCK SOLUTION WAS MIXED WITH HUMAN CK2ALPHA REMARK 280 (CONSTRUCT 1-335; PROTEIN CONCENTRATION 8-10 MG/ML IN 500 MM REMARK 280 SODIUM CHLORIDE, 25 MM TRIS/HCL PH 8.5) IN A RATIO OF 1:10. REMARK 280 AFTER A SHORT TIME OF INCUBATION, THIS MIXTURE WAS MIXED WITH REMARK 280 RESERVOIR SOLUTION [32 % (W/V) PEG4000, 0.2 M AMMONIUM ACETATE, REMARK 280 0.1 M CITRATE PH 5.6] IN A RATIO OF 5:2. 3.5 MICROLITER OF THESE REMARK 280 MIXTURES WERE THEN EQUILIBRATED AGAINST THE RESERVOIR SOLUTION. REMARK 280 THE CRYSTAL GROWTH WAS INDUCED BY SEEDING WITH 150 NANOLITER REMARK 280 SEEDING SUSPENSION AFTER AN EQUILIBRATION TIME OF TWO DAYS., REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.75250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 331 REMARK 465 ALA A 332 REMARK 465 ARG A 333 REMARK 465 MET A 334 REMARK 465 GLY A 335 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 123 O HOH A 501 2.05 REMARK 500 NH2 ARG A 278 OD1 ASP A 302 2.13 REMARK 500 O HOH A 655 O HOH A 657 2.13 REMARK 500 O HOH A 624 O HOH A 658 2.15 REMARK 500 O HOH A 563 O HOH A 671 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 58 99.84 -69.92 REMARK 500 PRO A 72 47.78 -80.33 REMARK 500 ASP A 156 41.53 -147.37 REMARK 500 ASP A 175 77.15 43.71 REMARK 500 ALA A 193 160.42 62.90 REMARK 500 MET A 208 59.87 -90.89 REMARK 500 HIS A 234 71.80 -105.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KC5 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 411 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5N9L RELATED DB: PDB REMARK 900 RELATED ID: 5N9K RELATED DB: PDB DBREF 5N9N A 1 335 UNP P68400 CSK21_HUMAN 1 335 SEQRES 1 A 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 335 VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 335 VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS ARG SEQRES 14 A 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY HET KC5 A 401 27 HET ACT A 402 4 HET ACT A 403 4 HET ACT A 404 4 HET ACT A 405 4 HET ACT A 406 4 HET GOL A 407 6 HET GOL A 408 6 HET GOL A 409 6 HET GOL A 410 6 HET GOL A 411 6 HETNAM KC5 (4~{Z})-7,9-BIS(CHLORANYL)-4-[[(4-METHOXYPHENYL) HETNAM 2 KC5 AMINO]METHYLIDENE]-8-OXIDANYL-1,2-DIHYDRODIBENZOFURAN- HETNAM 3 KC5 3-ONE HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 KC5 C20 H15 CL2 N O4 FORMUL 3 ACT 5(C2 H3 O2 1-) FORMUL 8 GOL 5(C3 H8 O3) FORMUL 13 HOH *175(H2 O) HELIX 1 AA1 ASP A 14 ARG A 19 1 6 HELIX 2 AA2 PRO A 20 ASP A 25 1 6 HELIX 3 AA3 TYR A 26 HIS A 29 5 4 HELIX 4 AA4 ASN A 35 ASP A 37 5 3 HELIX 5 AA5 LYS A 74 ARG A 89 1 16 HELIX 6 AA6 ASP A 120 GLN A 126 1 7 HELIX 7 AA7 THR A 129 MET A 150 1 22 HELIX 8 AA8 LYS A 158 HIS A 160 5 3 HELIX 9 AA9 SER A 194 LYS A 198 5 5 HELIX 10 AB1 GLY A 199 VAL A 204 1 6 HELIX 11 AB2 TYR A 211 ARG A 228 1 18 HELIX 12 AB3 ASP A 237 GLY A 250 1 14 HELIX 13 AB4 GLY A 250 TYR A 261 1 12 HELIX 14 AB5 ASP A 266 ILE A 272 5 7 HELIX 15 AB6 ARG A 280 VAL A 285 5 6 HELIX 16 AB7 ASN A 289 VAL A 293 5 5 HELIX 17 AB8 SER A 294 LEU A 305 1 12 HELIX 18 AB9 ASP A 308 ARG A 312 5 5 HELIX 19 AC1 THR A 314 GLU A 320 1 7 HELIX 20 AC2 HIS A 321 TYR A 325 5 5 SHEET 1 AA1 5 TYR A 39 ARG A 47 0 SHEET 2 AA1 5 SER A 51 ASN A 58 -1 O VAL A 53 N LEU A 45 SHEET 3 AA1 5 LYS A 64 LEU A 70 -1 O VAL A 67 N PHE A 54 SHEET 4 AA1 5 PRO A 109 GLU A 114 -1 O PHE A 113 N VAL A 66 SHEET 5 AA1 5 LEU A 97 LYS A 102 -1 N VAL A 101 O ALA A 110 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 CISPEP 1 GLU A 230 PRO A 231 0 -0.81 SITE 1 AC1 13 ARG A 43 LEU A 45 VAL A 53 VAL A 66 SITE 2 AC1 13 LYS A 68 PHE A 113 GLU A 114 VAL A 116 SITE 3 AC1 13 MET A 163 ILE A 174 ASP A 175 ACT A 405 SITE 4 AC1 13 HOH A 593 SITE 1 AC2 4 ARG A 80 ARG A 155 LEU A 178 ASN A 189 SITE 1 AC3 5 GLY A 90 GLY A 91 ASN A 93 ILE A 94 SITE 2 AC3 5 ARG A 172 SITE 1 AC4 4 ASP A 38 ILE A 59 PRO A 295 GLU A 296 SITE 1 AC5 5 SER A 51 VAL A 53 HIS A 160 KC5 A 401 SITE 2 AC5 5 HOH A 621 SITE 1 AC6 4 LYS A 229 PHE A 232 HOH A 509 HOH A 510 SITE 1 AC7 7 GLN A 36 TYR A 39 LEU A 41 ASP A 103 SITE 2 AC7 7 PRO A 104 ALA A 110 ARG A 280 SITE 1 AC8 4 ARG A 10 GLN A 310 ARG A 312 GLU A 317 SITE 1 AC9 4 SER A 194 ARG A 195 GOL A 410 HOH A 505 SITE 1 AD1 5 ARG A 191 ALA A 193 LYS A 198 GOL A 409 SITE 2 AD1 5 HOH A 521 SITE 1 AD2 6 LEU A 202 LEU A 203 ASN A 238 TYR A 239 SITE 2 AD2 6 PHE A 269 HOH A 638 CRYST1 57.477 45.505 63.489 90.00 110.97 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017398 0.000000 0.006670 0.00000 SCALE2 0.000000 0.021976 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016868 0.00000